Evidence map›Paper›PMID 40960440›Full record

ArticleJACC. Case reports2025

Efficacy of Novel Techniques Using a 4-F, 130-cm JR4.0 Catheter for Challenging Guiding Catheter Engagement.

Nobuo Ishiguro, Akimitsu Tanaka, Kohei Kitamura, Miyabi Ishikawa, Teppei Funasaka, Mami Fukujyu, Takeshi Mori, Makito Kaneshiro, Miyuki Ando, Kazuo Kato

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nobuo IshiguroDepartment of Cardiology, Nagoya Tokushukai General Hospital, Kasugai, Aichi, Japan. Electronic address: ishiguronobuo0707@gmail.com.
Akimitsu TanakaDepartment of Cardiology, Nagoya Tokushukai General Hospital, Kasugai, Aichi, Japan.
Kohei KitamuraDepartment of Cardiology, Nagoya Tokushukai General Hospital, Kasugai, Aichi, Japan.
Miyabi IshikawaDepartment of Cardiology, Nagoya Tokushukai General Hospital, Kasugai, Aichi, Japan.
Teppei FunasakaDepartment of Cardiology, Nagoya Tokushukai General Hospital, Kasugai, Aichi, Japan.
Mami FukujyuDepartment of Cardiology, Nagoya Tokushukai General Hospital, Kasugai, Aichi, Japan.
Takeshi MoriDepartment of Cardiology, Nagoya Tokushukai General Hospital, Kasugai, Aichi, Japan.
Makito KaneshiroDepartment of Cardiology, Nagoya Tokushukai General Hospital, Kasugai, Aichi, Japan.
Miyuki AndoDepartment of Cardiology, Nagoya Tokushukai General Hospital, Kasugai, Aichi, Japan.
Kazuo KatoDepartment of Cardiology, Nagoya Tokushukai General Hospital, Kasugai, Aichi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Percutaneous coronary intervention is a mature procedure with a high success rate. However, there are rare situations in which a guiding catheter cannot engage the coronary artery ostium, such as with an anomalous aortic origin of a coronary artery or interference from a transcatheter aortic valve implantation. This report presents 4 cases in which novel techniques using a 4-F, 130-cm JR4.0 catheter were successfully applied. This technique is especially valuable in patients with anomalous coronary artery origins or after transcatheter aortic valve implantation. Its use may improve procedural success, reduce contrast volume, and enhance wire control without the need for custom-shaped guiding catheters.

Indexed as

anomalous coronary arterycoronary access failureguide extension catheterpercutaneous coronary interventionthree-dimensional catheter shaping

Identifiers

PMID40960440
PMCPMC12790230

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.